CD4+ and CD8+ T cells each can utilize a perforin-dependent pathway to mediate lethal graft-versus-host disease in major histocompatibility complex- disparate recipients

Transplantation

Volumn 64, Issue 4, 1997, Pages 571-576

  Blazar, Bruce R ^a   Taylor, Patricia A ^a   Vallera, Daniel A ^a  

^a UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PERFORIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CYTOLYSIS; GRAFT VERSUS HOST REACTION; LETHAL DOSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SURVIVAL RATE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; BODY WEIGHT; BONE MARROW TRANSPLANTATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS II; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; PORE FORMING CYTOTOXIC PROTEINS; SPLEEN; SURVIVAL RATE; WHOLE-BODY IRRADIATION;

EID: 0030984020     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199708270-00004     Document Type: Article

References (33)

1. Ferrara JLM, Deeg HJ. Graft-versus-host disease. N Engl J Med 1991; 324: 667.
2. Berke G. CTL's kiss of death. Cell 1995; 81: 9.
3. Podack ER, Hengartner H, Lichtenheld MG. A central role for perform in cytolysis? Annu Rev Immunol 1991; 9: 129.
4. Watanabe-Fukunaga R, Brannan CI, Itoh N, et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 1992; 148: 1274.
5. Takahashi T, Tanaka M, Brannan CI, et al. Generalized lymphoproliferative disease in mice caused by a point mutation in the Fas ligand. Cell 1994; 76: 969.
6. Kagi D, Vignaux F, Ledermann B, et al. Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994; 265: 528.
7. Lowin B, Hahne M, Mattmann C, Tschopp J. Cytolytic T-cell cytotoxicity is mediated through perform and Fas lytic pathways. Nature 1994; 370: 650.
8. Masson DP, Corthesy P, Nabholz M, Tschopp J. Appearance of cytolytic granules upon induction of cytolytic activity in CTL hybrids. EMBO J 1985; 4: 2533.
9. Podack ER, Dennert G. Assembly of two types of tubules with putative cytolytic function by cloned natural killer cells. Nature 1983; 302: 442.
10. Lowrey DM, Aebischer T, Olsen KJ, et al. Cloning, analysis, and expression of murine perforin 1 cDNA, a component of cytolytic T-cell granules with homology to complement component C9. Proc Natl Acad Sci USA 1989; 86: 247.
11. Liu C-C, Walsh CM, Young JD-E. Perforin structure and function. Immunol Today 1995; 16: 194.
12. Heusel JW, Wesselschmidt RL, Shresta S, Russell JH, Ley TJ. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 1994; 76: 977.
13. Smyth MJ, Trapani JA. Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol Today 1995; 16: 202.
14. Jacobson S, Richert JR, Biddison WE, Satinsky A, Hartman RJ, McFarland HF. Measles virus-specific T4+ human cytotoxic T cell clones are restricted by class II HLA antigens. J Immunol 1984; 133: 754.
15. Littaua RA, Oldstone MB, Takeda A, Ennis FA. A CD4+ cytotoxic clone to a conserved epitope on human immunodeficiency virus type I p24: cytotoxic activity and secretion of interleukin-2 and interleukin-6. J Virol 1992; 66: 608.
16. Yasukawa M, Inatsuki A, Kobayashi Y. Differential in vitro activation of CD4+CD8- and CD8+CD4- herpes simplex virus-specific human cytotoxic T cells. J Immunol 1989; 143: 2051.
17. Lancki DW, Hsieh SC, Fitch FW. Mechanisms of lysis by cytotoxic T lymphocyte clones: lytic activity and gene expression in cloned antigen-specific CD4+ and CD8+ T lymphocytes. J Immunol 1991; 146: 3242.
18. Stalder T, Hahn S, Erb P. Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. J Immunol 1994; 152: 1127.
19. Ju S-T, Cui D, Panka J, Ettinger R, Marschak-Rothstein A. Participation of target Fas protein in apoptosis pathway induced by CD4+Th1 and CD8+ cytotoxic T cells. Proc Natl Acad Sci USA 1994; 91: 4185.
20. Graubert TA, Russell JH, Ley TJ. The role of granzyme B in murine models of acute graft-versus-host disease and graft rejection. Blood 1996; 87: 1232.
21. Blazar BR, Taylor PA, Panoskaltsis-Mortari A, et al. Blockade of CD40 ligand:CD40 interaction impairs CD4+ T cell mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation. J Immunol 1997; 158: 29.
22. + cells. J Exp Med 1994; 180: 307.
23. Walsh CM, Matloubian M, Liu CC, et al. Immune function in mice lacking the perform gene. Proc Natl Acad Sci USA 1994; 91: 10854.
24. Mantel N. Evaluation of survival data in two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163.
25. Williams NS, Engelhard VH. Identification of a population of CD4+ CTL that utilizes a perforin-rather than fas ligand-dependent cytotoxic mechanism. J Immunol 1996; 156: 153.
26. Baker MB, Altman NH, Podack ER, Levy RB. The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice. J Exp Med 1996; 183: 2645.
27. McCarthy PL Jr., Abhyankar S, Neben S, et al. Inhibition of interleukin-1 by an interleukin-1 receptor antagonist prevents graft-versus-host disease. Blood 1991; 78: 1915.
28. Blazar BR, Taylor PA, Gray GS, Vallera DA. The role of T cell subsets in regulating the in vivo efficacy of CTLA4-Ig in preventing graft-versus-host disease in recipients of fully MHC or minor histocompatibility (miH) only disparate donor inocula. Transplantation 1994; 58: 1422.
29. Piguet PF, Grau GE, Allet B, Vassalli P. Tumor necrosis factor/ cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease. J Exp Med 1987; 166: 1280.
30. Braun MY, Lowin B, French L, Acha-Orbea H, Tschopp J. Cytotoxic T cells deficient in both functional Fas ligand and perform show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J Exp Med 1996; 183: 657.
31. Via CS, Nguyen P, Shustov A, Drappa J, Elkon KB. A major role for the fas pathway in acute graft-versus-host disease. J Immunol 1996; 157: 5387.
32. Carter LL, Dutton RW. Relative perform- and fas-mediated lysis in T1 and T2 CD8 effector populations. J Immunol 1995; 155: 1028.
33. Baker MB, Riley RL, Podack ER, Levy RB. Graft-versus-host disease-associated lymphoid hypoplasia and B cell dysfunction is dependent upon donor cell-mediated fas-ligand function, but not perform function. Proc Natl Acad Sci USA 1997; 94: 1366.